Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy
Molecular Neurobiology · 2024-10 · 61 (10) · 7930-7949
DOI: 10.1007/s12035-024-04039-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, online erschienen am 05.03.2024. Verfasst von Ting Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, People's Republic of China. Hauptthemen laut MEDLINE: Reperfusion Injury, Phosphatidylinositol 3-Kinases, Signal Transduction, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 242 Literaturangaben.
Abstract (Originalsprache)
Ischemia/reperfusion (I/R) injury is a pathological event that results in reperfusion due to low blood flow to an organ. Cerebral ischemia is a common cerebrovascular disease with high mortality, and reperfusion is the current standard intervention. However, reperfusion may further induce cellular damage and dysfunction known as cerebral ischemia/reperfusion injury (CIRI). Currently, strategies for the clinical management of CIRI are limited, necessitating the exploration of novel and efficacious treatment modalities for the benefit of patients. PI3K/Akt signaling pathway is an important cellular process associated with the disease. Stimulation of the PI3K/Akt pathway enhances I/R injury in multiple organs such as heart, brain, lung, and liver. It stands as a pivotal signaling pathway crucial for diminishing cerebral infarction size and safeguarding the functionality of brain tissue after CIRI. During CIRI, activation of the PI3K/Akt pathway exhibits a protective effect on CIRI. Furthermore, activation of the PI3K/Akt pathway has the potential to augment the activity of antioxidant enzymes, resulting in a decrease in reactive oxygen species (ROS) and the associated oxidative stress. Meanwhile, PI3K/Akt plays a neuroprotective role by inhibiting inflammatory responses and apoptosis. For example, PI3K/Akt interacts with NF-κB, Nrf2, and MAPK signaling pathways to mitigate CIRI. This article is aimed to explore the pivotal role and underlying mechanism of PI3K/Akt in ameliorating CIRI and investigate the influence of ischemic preconditioning and post-processing, as well as the impact of pertinent drugs or activators targeting the PI3K/Akt pathway on CIRI. The primary objective is to furnish compelling evidence supporting the activation of PI3K/Akt in the context of CIRI, elucidating its mechanistic intricacies. By doing so, the paper aims to underscore the critical contribution of PI3K/Akt in mitigating CIRI, providing a theoretical foundation for considering the PI3K/Akt pathway as a viable target for CIRI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, People's Republic of China.
- Department of Neurology, The Second Hospital of Lanzhou University, Lanzhou, 730000, People's Republic of China.
- The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, People's Republic of China. wmx322@aliyun.com.
- Department of Neurology, The Second Hospital of Lanzhou University, Lanzhou, 730000, People's Republic of China. wmx322@aliyun.com.
Zitieren
APA
Zheng, T., Jiang, T., Ma, H., Zhu, Y., & Wang, M. (2024). Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy. Molecular Neurobiology, 61(10), 7930-7949. https://doi.org/10.1007/s12035-024-04039-1
Vancouver
Zheng T, Jiang T, Ma H, Zhu Y, Wang M. Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy. Molecular Neurobiology. 2024;61(10):7930-7949. doi:10.1007/s12035-024-04039-1
BibTeX
@article{Zheng2024,
author = {Zheng, Ting and Jiang, Taotao and Ma, Hongxiang and Zhu, Yanping and Wang, Manxia},
title = {Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy},
journal = {Molecular Neurobiology},
year = {2024},
volume = {61},
number = {10},
pages = {7930--7949},
doi = {10.1007/s12035-024-04039-1}
}
EUVIMED